688336 Stock Overview
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of antibody drugs in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥23.96 |
| 52 Week High | CN¥26.78 |
| 52 Week Low | CN¥16.02 |
| Beta | 0.30 |
| 1 Month Change | 5.09% |
| 3 Month Change | 24.15% |
| 1 Year Change | 26.44% |
| 3 Year Change | 47.54% |
| 5 Year Change | n/a |
| Change since IPO | -55.71% |
Recent News & Updates
Shareholder Returns
| 688336 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 10.2% | 5.0% | 3.1% |
| 1Y | 26.4% | -22.0% | -13.1% |
Return vs Industry: 688336 exceeded the CN Biotechs industry which returned -22% over the past year.
Return vs Market: 688336 exceeded the CN Market which returned -13.1% over the past year.
Price Volatility
| 688336 volatility | |
|---|---|
| 688336 Average Weekly Movement | 7.6% |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 688336 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688336's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 965 | n/a | www.3s-guojian.com |
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of antibody drugs in China. Its products include YISAIPU, a tumor necrosis factor inhibitor for rheumatism; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody injection; Cipterbin, an anti-HER2 monoclonal antibody. The company is also developing products for autoimmune diseases, tumors, and other diseases.
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Fundamentals Summary
| 688336 fundamental statistics | |
|---|---|
| Market cap | CN¥14.78b |
| Earnings (TTM) | CN¥352.22m |
| Revenue (TTM) | CN¥1.07b |
42.0x
P/E Ratio13.8x
P/S RatioIs 688336 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688336 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.07b |
| Cost of Revenue | CN¥227.16m |
| Gross Profit | CN¥846.43m |
| Other Expenses | CN¥494.21m |
| Earnings | CN¥352.22m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.57 |
| Gross Margin | 78.84% |
| Net Profit Margin | 32.81% |
| Debt/Equity Ratio | 1.0% |
How did 688336 perform over the long term?
See historical performance and comparison